San Diego-centered Viking Therapeutics marked itself as a significant competitor from the weight loss drug market in February after revealing promising information from a mid-phase demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when offered for a weekly injection As well as in March the company … Read More